ArticleBiomedical optics express2025
Chromatic imaging properties of myopia control spectacle lenses.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of Myopia Control Spectacle Lenses on Peripheral Refraction and Contrast: Insights From Optical Modeling.Investigative ophthalmology & visual science · 2026Article
- Role of light in eye growth and light as a therapy for myopia control.Frontiers in ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myopia progression in children can lead to ocular morbidity during adulthood. Spectacle lenses have been developed and commercialized for myopia control (MC), but their imaging properties have only been assessed under monochromatic illumination. In this study, we quantified the chromatic imaging properties (wavelengths, 450, 532 and 635 nm) of four MC lenses and a single vision lens at three retinal eccentricities (0°, 20° and 30°) along the horizontal meridian using spatial light modulation technology. Our results suggest that the design of myopia-control lenses based on simultaneous competing blurring should enhance the quality of images projected in front of the peripheral retina at long wavelengths.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.